Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
BLACKROCK INC BLK |
1,009,090 7.700% |
-863,811 (-46.12%) |
Filing History |
| 2023-02-14 4:34 pm Purchase |
2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Tarriff Scott | 2,533,457 18.060% |
113,483 (+4.69%) |
Filing History |
| 2023-02-13 09:26 am Sale |
2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
1,229,872 9.400% |
-298,280 (-19.52%) |
Filing History |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
The Vanguard Group | 763,807 5.870% |
3,339 (+0.44%) |
Filing History |
| 2023-02-03 4:08 pm Purchase |
2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
STATE STREET CORP STT |
952,026 7.310% |
243,802 (+34.42%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
BLACKROCK INC BLK |
1,872,901 14.400% |
0 (Unchanged) |
Filing History |
| 2023-01-20 3:00 pm Sale |
2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
BLACKROCK INC BLK |
1,872,901 14.400% |
-95,915 (-4.87%) |
Filing History |
| 2022-02-14 4:13 pm Sale |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Park West Asset Management LLC | 0 0.000% |
-791,600 (Position Closed) |
Filing History |
| 2022-02-14 4:00 pm Purchase |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Tarriff Scott | 2,419,974 17.610% |
99,355 (+4.28%) |
Filing History |
| 2022-02-11 09:41 am Sale |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
STATE STREET CORP STT |
708,224 5.480% |
-105,877 (-13.01%) |
Filing History |
| 2022-02-10 6:01 pm Sale |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
1,528,152 11.800% |
-165,921 (-9.79%) |
Filing History |
| 2022-02-09 3:43 pm Sale |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
The Vanguard Group | 760,468 5.890% |
-4,467 (-0.58%) |
Filing History |
| 2022-01-27 11:00 am Unchanged |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
BLACKROCK INC BLK |
1,968,816 15.200% |
0 (Unchanged) |
Filing History |
| 2022-01-25 3:03 pm Purchase |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
BLACKROCK INC BLK |
1,968,816 15.200% |
27,800 (+1.43%) |
Filing History |
| 2021-02-16 5:20 pm Purchase |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Tarriff Scott | 2,320,619 16.660% |
181,403 (+8.48%) |
Filing History |
| 2021-02-16 4:34 pm Sale |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Park West Asset Management LLC | 791,600 6.100% |
-380,280 (-32.45%) |
Filing History |
| 2021-02-16 3:07 pm Sale |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Armistice Capital, LLC | 364,000 2.800% |
-392,000 (-51.85%) |
Filing History |
| 2021-02-11 4:39 pm Sale |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
1,694,073 13.000% |
-105,636 (-5.87%) |
Filing History |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
The Vanguard Group | 764,935 5.870% |
4,565 (+0.60%) |
Filing History |
| 2021-02-08 1:14 pm Purchase |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
STATE STREET CORP STT |
814,101 6.250% |
203,510 (+33.33%) |
Filing History |